From $250 · $250 consult · 4.9★ on Trustpilot · All 50 States
850 verified reviews
Hair loss in a hormone-optimization context — useful where DHT or thyroid drives the pattern, overkill for straightforward androgenic alopecia.
Detailed intake covering hair-loss pattern (Norwood stage, onset timing, family history), prior treatment exposure, current medications, broader hormonal symptoms, and treatment goals. Schedule the initial physician consult — Marek's onboarding consults run 30–60 min, addressing hair loss in the context of the broader hormone picture rather than in isolation.
Video consult with a licensed physician. Lab order typically includes hormone panel (total T, free T, DHT, sensitive estradiol, SHBG), thyroid (T3, T4, RT3, TSH, antibodies), and iron status (ferritin, transferrin saturation). Iron deficiency is a documented contributor to androgenic alopecia that mass-market hair-loss telehealth rarely tests for. Local LabCorp or Quest draw; results in 3–5 business days.
Lab review with the prescriber confirms protocol match. First prescription shipped — typically oral finasteride 1mg (standard first-line) plus addressing any identified contributing factors (iron supplementation, thyroid medication adjustment, etc.). Initial shedding phase begins in weeks 2–8; this is normal turnover, not treatment failure. Some men begin seeing reduced loss by month 2–3 but measurable regrowth requires longer.
Real response window for finasteride. Photo comparisons against baseline typically show stabilization or modest regrowth in responders. For non-responders, Marek's clinical depth enables conversations about adding minoxidil, topical finasteride formulations, dutasteride off-label, or routing to hair-restoration specialists for procedural evaluation — conversations that mass-market hair-loss telehealth often doesn't engage with.
[PeterMD](/online-providers/hair-loss/petermd) is the mass-market finasteride operation at $60/mo entry plus the ReGenX bundle option for combination therapy. Marek is the premium-concierge model integrating hair loss into broader hormone-and-metabolic context — DHT testing, thyroid panel, iron status. PeterMD's strength is operational efficiency and pricing for straightforward cases. Marek's strength is clinical context for cases where hair loss is part of a broader hormone picture or where prior finasteride monotherapy didn't fully resolve. AHF rates Marek 4.2 and PeterMD 3.9 (hair-loss). Pick PeterMD for cost-conscious early-stage cases. Pick Marek for layered hormone-context cases or existing Marek hormone patients.
[Hims](/online-providers/hair-loss/hims) is the category-leading entry-priced finasteride telehealth at $22/mo basic monotherapy. Marek is the premium-concierge model — comprehensive panel including DHT/thyroid/iron status, longer prescriber consults, integrated hormone context. The price differential is significant: Marek's all-in monthly typically runs 10–15× Hims basic entry. The clinical case for Marek over Hims has to overcome that pricing gap — and it does, but only for the case profile where the additional clinical depth changes the protocol decision. AHF rates Marek 4.2 and Hims 4.0 (hair-loss). Pick Hims for straightforward basic finasteride at the lowest cost. Pick Marek if hair loss is part of a broader hormone picture requiring clinical context.
Yes — Marek operates as a licensed U.S. telehealth practice with physicians in each state served, dispenses generic finasteride from FDA-registered pharmacies, and maintains the same legitimacy infrastructure as their TRT and peptide-therapy lanes (licensed prescribers, real lab orders, structured monitoring). The hair-loss line is a smaller piece of Marek's overall practice than TRT or peptide-therapy, but operates under the same clinical model. The premium pricing reflects the clinical depth (DHT + thyroid + iron panel work) rather than corner-cutting on the medication.
Free consultation. Independently reviewed. Board-certified physicians.
Get Free ConsultationSecure telemedicine · HIPAA compliant · Cancel anytime